UChicago Medicine Faculty Physicians
Azhar M. Awan, MD
Azhar M. Awan, MD
UChicago Medicine Faculty Physicians
Clinical Associate Professor of Radiation and Cellular Oncology
Medical Director, Radiation Oncology for Sherman Hospital
Specialties
- Radiation Oncology
Locations
- New Lenox - Cancer Center at Silver Cross Hospital
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Azhar M. Awan, MD, specializes in treating all solid tumors and lymphomas. He is particularly skilled in the treatment of prostate cancer, soft tissue sarcomas and breast cancer. Dr. Awan is an expert in leading edge cancer treatments, including intensity-modulated radiation therapy (IMRT) and 3-D conformal radiation therapy. He also is skilled in the use of unsealed radioactive sources for treating painful bone metastases.
Dr. Awan has been a contributing researcher in several cancer studies, including early trials that formed the basis of the multidisciplinary head and neck cancer program at the University of Chicago Medicine. These studies evaluated the combined use of radiation therapy and chemotherapy against both untreated and previously irradiated head and neck cancers, using a unique every-other-week treatment schedule. Dr. Awan also has contributed to both the Prostate Cancer Prevention Trial and the SELECT study -- an investigation of vitamin E and selenium in the possible prevention of prostate cancer.
Dr. Awan regularly appears on the Castle Connolly Medical Ltd.'s list of "Top Doctors" in Chicago and in America.
Dr. Awan has been a contributing researcher in several cancer studies, including early trials that formed the basis of the multidisciplinary head and neck cancer program at the University of Chicago Medicine. These studies evaluated the combined use of radiation therapy and chemotherapy against both untreated and previously irradiated head and neck cancers, using a unique every-other-week treatment schedule. Dr. Awan also has contributed to both the Prostate Cancer Prevention Trial and the SELECT study -- an investigation of vitamin E and selenium in the possible prevention of prostate cancer.
Dr. Awan regularly appears on the Castle Connolly Medical Ltd.'s list of "Top Doctors" in Chicago and in America.
Specialties
Areas of Expertise
UChicago Medicine Cancer Care at Silver Cross Hospital - New Lenox1850 Silver Cross Blvd. Carolyn J. Czerkies Pavilion, New Lenox IL 604511-855-826-1400
Board Certifications
- Medical Physics (Diagnostic
- Nuclear
- Therapeutic)
Practicing Since
- 1985
Languages Spoken
- English
- Punjabi
- Swahili
- Urdu
Medical Education
- Loyola University Stritch School of Medicine
Internship
- Henry Ford Hospital
Residency
- St. Luke's Medical Center
Memberships & Medical Societies
- American College of Radiation Oncology
- American Society for Radiation Oncology
- American Society of Clinical Oncology
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
*Click Here to visit our insurance page and learn more.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.